ArticlePakistan journal of medical sciences2026
Trastuzumab Deruxtecan as a Salvage Therapy after Disitamab Vedotin Failure in HER2 Altered Solid Tumors: A Preliminary Real-world Comparative Study.
Lihong Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.